Recently added
This page was added on 04 June 2018.
Updates made
This page was updated on [date-counter-updated-date]. View history of updates
Sponsor
GlaxoSmithKline Australia
Administration route
Intramuscular injection
Vaccine group
Monovalent vaccines
Description:
Registered for use in people aged 2–15 years.
Each 0.5 mL monodose vial or pre-filled syringe contains:
- 720 ELISA units of inactivated hepatitis A virus (HM175 strain)
- 0.25 mg aluminium as aluminium hydroxide hydrate
Also contains traces of:
- formaldehyde
- neomycin
- polysorbate 20
For Product Information and Consumer Medicine Information about Havrix Junior visit the Therapeutic Goods Administration website.
Additional vaccine information
For detailed advice on vaccine dosage, administration, contraindications and precautions, and variations from product information, please visit the relevant disease chapter/s.
Page history
Last updated
Last reviewed
Related diseases